In a groundbreaking effort to advance nanosafety and innovation, researchers from University College Dublin (UCD), as part of the EU-funded nanoPASS project, are shedding light on the critical role of the bionano interface. This tiny boundary, where biological and inorganic materials interact, holds the key to major advancements in fields ranging from medicine to cosmetics and food processing. Yet, understanding this interface remains a significant challenge due to the complex nature of these interactions.
Image courtesy of the nanoPASS project
The nanoPASS project, in which NIA is partner, aims to address this complexity by developing advanced computational models to better understand how nanoparticles interact with biological systems. This research is essential for creating safer and more effective nano-enabled products while moving towards animal-free screening methods for nanosafety assessments. With the increasing use of nanoparticles in everyday products, these insights are crucial for ensuring both innovation and safety across multiple industries.
The project's findings not only contribute to more efficient risk assessments but also pave the way for safer, more sustainable nanotechnologies. As the research progresses, the nanoPASS project continues to refine models that will empower industries and regulators to assess nanoparticle risks more accurately and swiftly.
By focusing on the bionano interface, the nanoPASS project is shaping the future of nanotechnology, ensuring that innovation is both cutting-edge and safe for widespread use.
For more details on the nanoPASS project and its recent publication, read the full article on the project website.
